Quest Diagnostics Inc vs Noble Corporation plc — how do they compare? Quest Diagnostics Inc trades at $205.45 (market cap $22.95B), while Noble Corporation plc trades at $41.68 (market cap $6.67B). The key difference: Quest Diagnostics Inc is far larger — about 3.4× Noble Corporation plc's market cap, and Noble Corporation plc pays the higher dividend (4.79%). Which is the better fit depends on your goals.
| DGX | NE | |
|---|---|---|
Market Cap | $22.95B | $6.67B |
Sector | Health | Technology |
52-Week High | $216.02 | $54.37 |
52-Week Low | $166.42 | $25.70 |
Enterprise Value | $28.97B | $7.92B |
Dividend Yield | 1.66% | 4.79% |
Trailing returns across standard periods
Latest headlines on both assets
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
Read more on DGX →Noble Corporation plc is a leading offshore drilling contractor for the oil and gas industry. The company owns and operates a high-specification fleet of mobile offshore drilling units, including drillships and semi-submersibles, that are used for exploration and production activities in deepwater and harsh environments worldwide. Noble focuses on providing safe, efficient, and reliable drilling services to major and independent oil and gas companies globally.
Read more on NE →